VILAB II HISTORY

Vilab was established in 1974 by The Lindsley F. Kimball Research Institute of The New York Blood Center (LFKRI) at The Liberian Institute for Biomedical Research in Robertsfield, Liberia. The laboratory was established with the following goals:

1. To carry out research with chimpanzees devoted to the development of vaccines and immunotherapy for hepatitis B and C viruses.

2. To develop means for eliminating transmission of viruses by blood products.

3. To develop a vaccine against Onchocerciasis (River Blindness).

4. To humanely maintain chimpanzees used in research, with respect for their social and psychological needs.

5. To provide for the lifelong retirement of Vilab chimpanzees under wild or semi-wild conditions. The last two goals were major factors why Liberia was chosen as a site for this laboratory.

Contact Information:
Director of Development: Lisa T. Fishler
553 Salt Point Turnpike
Poughkeepsie, New York 12601
heprf@heprf.org

HRF is recognized by the Internal Revenue Service as a public charity
under section 501(c)(3) of the Internal Revenue Code.
EIN #14-1807382

For exciting New Research
CLICK HERE

The Foundation thanks Adobe's Gifts in Kind program for their generous contribution.

The Hepatitis Research Foundation would like to thank the Don and Rita Lee Foundation for their continuous support for immunotherapy of chronic HCV infection.

We subscribe to the HONcode principles of the Health On the Net Foundation.